Markedly improving survival of neuroblastoma: a 30-year analysis of 1,646 patients

O’Neill JA (1998) Pediatric surgery, 5th edn. Mosby-Year Book, St. Louis Kim S, Chung DH (2006) Pediatric solid malignancies: neuroblastoma and Wilms’ tumor. Surg Clin North Am 86(2):469–487, xi Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP et al (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11(8):1466–1477 Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK et al (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children’s Cancer Group. N Engl J Med 341(16):1165–1173 Kohler JA, Imeson J, Ellershaw C, Lie SO (2000) A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy. Br J Cancer 83(9):1124–1127 Cheung NK, Kushner BH, Kramer K (2001) Monoclonal antibody-based therapy of neuroblastoma. Hematol Oncol Clin North Am 15(5):853–866 Cheung NK (2000) Monoclonal antibody-based therapy for neuroblastoma. Curr Oncol Rep 2(6):547–553 Matthay KK (1999) Intensification of therapy using hematopoietic stem-cell support for high-risk neuroblastoma. Pediatr Transplant 3(Suppl 1):72–77 Institute NC (2005) Surveillance, epidemiology and end results (SEER) program Fritz A (2000) International classification of diseases for oncology: ICD-O, 3rd edn. World Health Organization, Geneva Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D’Angio G et al (1988) International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6(12):1874–1881 Gurney JG, Severson RK, Davis S, Robison LL (1995) Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 75(8):2186–2195 Grovas A, Fremgen A, Rauck A, Ruymann FB, Hutchinson CL, Winchester DP et al (1997) The national cancer data base report on patterns of childhood cancers in the United States. Cancer 80(12):2321–2332 Joshi VV, Cantor AB, Altshuler G, Larkin EW, Neill JS, Shuster JJ et al (1992) Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the pediatric oncology group. Cancer 69(8):2197–2211 DuBois SG, Kalika Y, Lukens JN, Brodeur GM, Seeger RC, Atkinson JB et al (1999) Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol 21(3):181–189 Matthay KK, Perez C, Seeger RC, Brodeur GM, Shimada H, Atkinson JB et al (1998) Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children’s cancer group study. J Clin Oncol 16(4):1256–1264 Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC et al (1991) Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a pediatric oncology group study. J Clin Oncol 9(4):581–591 London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H et al (2005) Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children’s oncology group. J Clin Oncol 23(27):6459–6465 Schmidt ML, Lal A, Seeger RC, Maris JM, Shimada H, O’Leary M et al (2005) Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children’s cancer group study. J Clin Oncol 23(27):6474–6480 George RE, London WB, Cohn SL, Maris JM, Kretschmar C, Diller L et al (2005) Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a pediatric oncology group study. J Clin Oncol 23(27):6466–6473 Strother D, Shuster JJ, McWilliams N, Nitschke R, Smith EI, Joshi VJ et al (1995) Results of pediatric oncology group protocol 8104 for infants with stages D and DS neuroblastoma. J Pediatr Hematol Oncol 17(3):254–259 Gaspar N, Hartmann O, Munzer C, Bergeron C, Millot F, Cousin-Lafay L et al (2003) Neuroblastoma in adolescents. Cancer 98(2):349–355 Hsu WM, Jen YM, Lee H, Kuo ML, Tsao PN, Chen CN et al (2006) The influence of biologic factors on the surgical decision in advanced neuroblastoma. Ann Surg Oncol 13(2):238–244 Evans AE, Albo V, D’Angio GJ, Finklestein JZ, Leiken S, Santulli T et al (1976) Cyclophoshamide treatment of patients with localized and regional neuroblastoma: a randomized study. Cancer 38(2):655–660 Koop CE, Schnaufer L (1975) The management of abdominal neuroblastoma. Cancer 35(3 suppl):905–909 Koop CE, Johnson DG (1971) Neuroblastoma: an assessment of therapy in reference to staging. J Pediatr Surg 6(5):595–600 von Allmen D, Grupp S, Diller L, Marcus K, Ecklund K, Meyer J et al (2005) Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant. J Pediatr Surg 40(6):936–41; discussion 941 Castleberry RP, Kun LE, Shuster JJ, Altshuler G, Smith IE, Nitschke R et al (1991) Radiotherapy improves the outlook for patients older than 1 year with pediatric oncology group stage C neuroblastoma. J Clin Oncol 9(5):789–795 Haas-Kogan DA, Swift PS, Selch M, Haase GM, Seeger RC, Gerbing RB et al (2003) Impact of radiotherapy for high-risk neuroblastoma: a Children’s cancer group study. Int J Radiat Oncol Biol Phys 56(1):28–39 Marcus KJ, Shamberger R, Litman H, von Allmen D, Grupp SA, Nancarrow CM et al (2003) Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants. J Pediatr Hematol Oncol 25(12):934–940